Polfa Warszawa to self-finance its investments in new pharmaceutical plant

Polfa Warszawa, the largest exporter of pharmaceuticals, is to invest over zl. 45 million in 2002. One key element of the investment plan is the construction of a new plant in the special economic zone of Tarnobrzeg, and the promotion of new medicines on the domestic and foreign markets. "The plant will be ready in 2004. The total cost of construction and equipment will amount to over zl. 80 million. It will employ over 120 people," said Wladyslaw Karas, the company director. All the investments will be covered from the company's own funds, without any loans. Polfa Warszawa exports around 35% of its total production. The value of these export exceeds zl. 80 million. Over the past eight years the company has spent over zl. 300 million on investments. (Rzeczpospolita, p. B3) A.K.